Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001104659-25-019062
Filing Date
2025-02-28
Accepted
2025-02-28 15:00:50
Documents
6

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 18572
2 PART II AND III tm2427963d7_partiiandiii.htm PART II AND III 1781796
3 EXHIBIT 11.1 tm2427963d7_ex11-1.htm EX1A-11 CONSENT 2155
4 GRAPHIC tm2427963d7_partiiandiiiimg1.jpg GRAPHIC 21998
5 GRAPHIC tm2427963d7_partiiandiiiimg2.jpg GRAPHIC 36278
6 GRAPHIC tm2427963d7_partiiandiiiimg3.jpg GRAPHIC 10019
  Complete submission text file 0001104659-25-019062.txt   1898325
Mailing Address 658 W. INDIANTOWN ROAD SUITE 214 JUPTER FL 33458
Business Address 658 W INDIANTOWN RD SUITE 214 JUPITER FL 33458-7535 (561) 575-4451
Cytonics Corp (Filer) CIK: 0001421744 (see all company filings)

EIN.: 208883869 | State of Incorp.: FL
Type: 1-A/A | Act: 33 | File No.: 024-12533 | Film No.: 25688587
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)